13th Feb 2008 12:15
Oxford Biomedica PLC13 February 2008 For Immediate Release 13 February 2008 OXFORD BIOMEDICA TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii): Oxford BioMedica PLC 2. Reason for the notification An acquisition or disposal of voting rights: (Yes) 3. Full name of person(s) subject to the notification obligation (iii): MF Global UK Limited 4. Full name of shareholder(s) (if different from 3.) (iv): 5. Date of the transaction (and date on which the threshold is crossed orreached if different) (v): 12 February 2008 6. Date on which issuer notified: 13 February 2008 7. Threshold(s) that is/are crossed or reached: Below 3% 8. Notified details: A: Voting rights attached to shares Class/type of shares Situation previous to the Triggering transactionif possible using (vi)the ISIN CODE Number of shares Number of voting Rights (viii)GB0006648157 18,325,176 18,325,176 Resulting situation after the triggering transaction (vii)Class/type of shares Number of shares Number of voting % of votingif possible using rights (ix) rightsthe ISIN CODE Direct Direct (x) Indirect Direct Indirect (xi)GB0006648157 Below 3% Below 3% Below 3% B: Financial Instruments Resulting situation after the triggering transaction (xii)Type of Expiration Date Exercise/Conversion Number of voting % of votingfinancial (xiii) Period/Date (xiv) rights that may be rightsinstrument acquired if the instrument is exercised/ converted.N/A N/A N/A N/A N/A Total (A+B) Number of voting rights % of voting rights 7,689,280 Below 3% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv): Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: None 14. Contact name: Andrew Wood 15. Contact telephone number: 01865 783000 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Oxford Biomedica